Gå direkt till huvudinnehållet

Proteinuri

Senast uppdaterad: Senast reviderad:
Sakkunnig:


  1. Viswanathan G, Upadhyay A. Assessment of proteinuria. Adv Chronic Kidney Dis. 2011;18:243-248. PubMed  
  2. Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80:17-28. PubMed  
  3. Bulatov VA, Stenehjem A, Os I. Association between albumin: creatinine ratio and 24-hour ambulatory blood pressure in essential hypertension. Am J Hypertens 2001; 14: 338 - 44. PMID: 11336179 PubMed  
  4. Waheed S. Assessment of proteinuria. BestPractice, last updated Sep 17, 2014.
  5. Clausen P, Jensen JS, Jensen G, Borch-Johnsen K, Feldt-Rasmussen B. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 2001; 103: 1869 - 74. PMID: 11294805 PubMed  
  6. Keane WF. Proteinuria: its clinical importance and role in progressive renal disease. Am J Kidney Dis 2000; 35 (suppl): 97 - 105. PMID: 10766008 PubMed  
  7. National Kidney Foundation. KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1-S266. PMID: 11904577 PubMed  
  8. Leung AKC, Wong AHC. Proteinuria in children. Am Fam Physician 2010; 82: 645-51. PMID: 20842993 PubMed  
  9. Carroll MF, Temte JL. Proteinuria in adults: A diagnostic approach. Am Fam Physician 2000; 62: 1333-40. PMID: 11011862 PubMed  
  10. Tidig upptäckt och initial utredning av kronisk njursjukdom. Riktlinjer för preventiv nefrologi i Södra sjukvårdsregionen. Godkänd sept 2011, 2013. Reviderad sept 2016. Giltig till okt 2019. Ansvar RMK njurmedicin, RMK allmänmedicin www.egfr.se  
  11. Draganov B, Andersson K, Os I. Proteinuri. Tidsskr Nor Lægeforen 1999; 119: 2845. PubMed  
  12. Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, Marcantoni C for the AIPRD Study Group. Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Angiotensin-converting enzyme inhibition and progression of renal disease. Kidney Int 2001; 60: 1131 - 40. PubMed  
  13. Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury. Am J Kidney Dis 2000; 35: 1155 - 65. PubMed  
  14. Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH. Progression of diabetic nephropathy. Kidney Int 2001; 59: 702 - 9. PubMed  
  15. Benigni A, Remuzzi G. How renal cytokines and growth factors contribute to renal disease progression. Am J Kidney Dis 2001; 37 (suppl): 21 - 4. PMID: 11158856 PubMed  
  16. Hartmann A, Jenssen T, Midtvedt K, et al. Protein-kreatinin-ratio - en enkel metode for vurdering av proteinuri i klinisk praksis. Tidsskr Nor Lægeforen 2002;122:2180-3. PubMed  
  17. Perico N, Remuzzi A, Sangalli F, Azzollini N, Mister M, Ruggenenti P et al. The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin. J Am Soc Nephrol 1998; 9: 2308 - 17. PubMed  
  • Anna Nager, med dr och specialist i allmänmedicin, Karolinska institutet